MTNB 8-K 2026-11-03

Matinas BioPharma Holdings, Inc. (MTNB) 8-K dated 2026-11-03 — accession 0001493152-26-049802.

Matinas BioPharma Holdings, Inc. (MTNB) is a biotechnology company listed on US.

Matinas BioPharma Holdings, Inc. filed a 8-K on 2026-11-03. Accession 0001493152-26-049802.

This 8-K covers: Other events (Item 8.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported MTNB revenue for 2023-09-30 was $1.1M. Net income was -$6.1M. Revenue was up 0.0% from 2023-06-30 to 2023-09-30. MTNB currently screens at market cap $5.6M.

Not investment advice. The MTNB SEC hub lists recent forms. The stock page is the research view.